BACKGROUND: Cartilage-hair hypoplasia (CHH) is characterized by metaphyseal dysplasia, bone marrow failure, increased risk of malignancies, and a variable degree of immunodeficiency. CHH is caused by mutations in the RNA component of the mitochondrial RNA processing (RMRP) endoribonuclease gene, which is involved in ribosomal assembly, telomere function, and cell cycle control. OBJECTIVES: We aimed to define thymic output and characterize immune function in a cohort of patients with molecularly defined CHH with and without associated clinical immunodeficiency. METHODS: We studied the distribution of B and T lymphocytes (including recent thymic emigrants), in vitro lymphocyte proliferation, cell cycle, and apoptosis in 18 patients with CHH compared with controls. RESULTS: Patients with CHH have a markedly reduced number of recent thymic emigrants, and their peripheral T cells show defects in cell cycle control and display increased apoptosis, resulting in poor proliferation on activation. CONCLUSION: These data confirm that RMRP mutations result in significant defects of cell-mediated immunity and provide a link between the cellular phenotype and the immunodeficiency in CHH.
BACKGROUND:Cartilage-hair hypoplasia (CHH) is characterized by metaphyseal dysplasia, bone marrow failure, increased risk of malignancies, and a variable degree of immunodeficiency. CHH is caused by mutations in the RNA component of the mitochondrial RNA processing (RMRP) endoribonuclease gene, which is involved in ribosomal assembly, telomere function, and cell cycle control. OBJECTIVES: We aimed to define thymic output and characterize immune function in a cohort of patients with molecularly defined CHH with and without associated clinical immunodeficiency. METHODS: We studied the distribution of B and T lymphocytes (including recent thymic emigrants), in vitro lymphocyte proliferation, cell cycle, and apoptosis in 18 patients with CHH compared with controls. RESULTS:Patients with CHH have a markedly reduced number of recent thymic emigrants, and their peripheral T cells show defects in cell cycle control and display increased apoptosis, resulting in poor proliferation on activation. CONCLUSION: These data confirm that RMRP mutations result in significant defects of cell-mediated immunity and provide a link between the cellular phenotype and the immunodeficiency in CHH.
Authors: M Ridanpää; H van Eenennaam; K Pelin; R Chadwick; C Johnson; B Yuan; W vanVenrooij; G Pruijn; R Salmela; S Rockas; O Mäkitie; I Kaitila; A de la Chapelle Journal: Cell Date: 2001-01-26 Impact factor: 41.582
Authors: Victoria Bordon; Andrew R Gennery; Mary A Slatter; Els Vandecruys; Genevieve Laureys; Paul Veys; Waseem Qasim; Qasim Waseem; Wilhelm Friedrich; Nico M Wulfraat; Franziska Scherer; Andrew J Cant; Alain Fischer; Marina Cavazzana-Calvo; Marina Cavazanna-Calvo; Robbert G M Bredius; Luigi D Notarangelo; Evelina Mazzolari; Benedicte Neven; Tayfun Güngör; Güngör Tayfun Journal: Blood Date: 2010-04-07 Impact factor: 22.113
Authors: Dina M Aresvik; Torstein Øverland; Kari Lima; Rolf D Pettersen; Tore G Abrahamsen Journal: J Clin Immunol Date: 2018-12-19 Impact factor: 8.317
Authors: Leslie E Rogler; Brian Kosmyna; David Moskowitz; Remon Bebawee; Joseph Rahimzadeh; Katrina Kutchko; Alain Laederach; Luigi D Notarangelo; Silvia Giliani; Eric Bouhassira; Paul Frenette; Jayanta Roy-Chowdhury; Charles E Rogler Journal: Hum Mol Genet Date: 2013-09-05 Impact factor: 6.150